Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | MYLOTARG |
|---|---|
| Manufacturer | Pfizer Pharma GmbH |
| Prescription required | Yes |
Mylotarg 5mg pik (gemtuzumab ozogamicin)
Gemtuzumab Ozogamicin
Description
Mylotarg 5mg pik (gemtuzumab ozogamicin) is a medicine catalog record in the MediPriceHub database. Active ingredient: Gemtuzumab Ozogamicin. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Pfizer Pharma GmbH. Therapeutic category: Medicine Library > Oncology Medicines > Leukemia Medicines. Pack information: 5. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
MYLOTARG is a CD33-directed antibody and cytotoxic drug conjugate indicated for: • treatment of newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and pediatric patients 1 month and older . • treatment of relapsed or refractory CD33-positive AML in adults and pediatric patients 2 years and older .How to Use
Use Gemtuzumab Ozogamicin under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: Gemtuzumab Ozogamicin. Pack size: 5. Pack unit: bottle. Manufacturer: Pfizer Pharma GmbH. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Leukemia Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.